May 12 (Reuters) - Trillium Therapeutics Inc TRIL.TO :
* Trillium reports first quarter 2017 financial and operating results
* Qtrly basic and diluted loss per common share $1.46
* Trillium Therapeutics- net loss for three months ended March 31, 2017 of $11.5 million was higher than loss of $7.2 million for three months ended March 31, 2016
* Qtrly net loss was higher due mainly to increased research and development program expenses of $2.8 million
* All figures in C$ Source text for Eikon: ID:nCCN5cywhZ Further company coverage: TRIL.TO